Inovio Pharmaceuticals Inc banner

Inovio Pharmaceuticals Inc
LSE:0A43

Watchlist Manager
Inovio Pharmaceuticals Inc Logo
Inovio Pharmaceuticals Inc
LSE:0A43
Watchlist
Price: 1.2299 USD -3.16%
Market Cap: $84.5m

Wall St Price Targets

0A43 Price Targets Summary
Inovio Pharmaceuticals Inc

Wall Street analysts forecast 0A43 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 0A43 is 6.8463 USD with a low forecast of 1.8051 USD and a high forecast of 13.5532 USD.

Lowest Forecast
Price Target
1.8051 USD
47% Upside
Average Forecast
Price Target
6.8463 USD
457% Upside
Highest Forecast
Price Target
13.5532 USD
1 002% Upside
Inovio Pharmaceuticals Inc Competitors:
Price Targets
IPAR
Inter Parfums Inc
21% Upside
ACAD
ACADIA Pharmaceuticals Inc
54% Upside
CFFN
Capitol Federal Financial Inc
7% Upside
QTTB
Homology Medicines Inc
33% Upside

Revenue
Forecast

-30% / Year
Past Growth
181% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
-30% / Year
Past Growth
181% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been -30%. The projected CAGR for the next 8 years is 181%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-90%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-90%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 0A43's stock price target?
Price Target
6.8463 USD

According to Wall Street analysts, the average 1-year price target for 0A43 is 6.8463 USD with a low forecast of 1.8051 USD and a high forecast of 13.5532 USD.

What is the Revenue forecast for Inovio Pharmaceuticals Inc?
Projected CAGR
181%

Over the last 14 years, the compound annual growth rate for Revenue has been -30%. The projected CAGR for the next 8 years is 181%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett